학술논문
First-in-human first-in-class phase I trial of murlentamab, an anti-Mullerian-hormone receptor II (AMHRII) monoclonal antibody acting through tumor-associated macrophage (TAM) engagement, as single agent and in combination with carboplatin (C) and paclitaxel (P) in AMHRII-expressing advanced/metastatic gynecological cancer patients (pts)
Document Type
Journal
Author
Leary, Alexandra; Awada, Ahmad; Delord, Jean-Pierre; Floquet, Anne; Ray-Coquard, Isabelle Laure; Abdeddaim, Cyril; Fabbro, Michel; Kalbacher, Elsa; Vergote, Ignace; Banerjee, Susana N.; Frenois, Francois-Xavier; Noel, Gregory; Lantz, Olivier; Cassard, Lydie; Coste, Agnes; Villard, Marine; Lemee, Fanny; Tabah-Fisch, Isabelle Marie; Le Tourneau, Christophe
Source
Subject
Language
English
ISSN
15277755